APA (7th ed.) Citation

Chi, Y. (2018). Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. The American Association for Cancer Research (AACR).

Chicago Style (17th ed.) Citation

Chi, Y. Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. The American Association for Cancer Research (AACR), 2018.

MLA (9th ed.) Citation

Chi, Y. Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. The American Association for Cancer Research (AACR), 2018.

Warning: These citations may not always be 100% accurate.